Neuberg Diagnostics gets ICMR nod to conduct COVID-19 tests in 4 cities

Published On 2021-01-19 06:38 GMT   |   Update On 2021-01-19 06:38 GMT

Chennai: Leading diagnostics lab chain Neuberg Diagnostics on Monday said it has received approval from the Indian Council of Medical Research to conduct COVID-19 tests in Tamil Nadu, Kerala, Andhra Pradesh and in the Delhi National Capital Region. The laboratories would come up at Noida, Visakhapatnam, Salem and Kozhikode. The facilities would have capacity to process close to 7,000...

Login or Register to read the full article

Chennai: Leading diagnostics lab chain Neuberg Diagnostics on Monday said it has received approval from the Indian Council of Medical Research to conduct COVID-19 tests in Tamil Nadu, Kerala, Andhra Pradesh and in the Delhi National Capital Region.

The laboratories would come up at Noida, Visakhapatnam, Salem and Kozhikode. The facilities would have capacity to process close to 7,000 Reverse Transcription Polymerase Chain Reaction test samples every day, a press release here said.

Currently, Neuberg conducts RT-PCR tests at its labs in Chennai, Tiruchirappalli, Kochi, Hyderabad, Bengaluru, Pune, Surat, Indore and Udaipur. The company also said it would expand the setting up of RT-PCR test counters in Lucknow and at Mangalore airports.

Read also: AstraZeneca lung cancer drug Imfinzi gets nod for new dosing regimen in EU, UK

A similar facility already exists at the Ahmedabad airport. The tests would be available for all international arrivals as well as domestic travellers and a hard copy of the test result would be provided within 6-8 hours to all passengers undergoing COVID-19 test, the release said.


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News